郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Synthesis and pharmacological evaluation of analogues of benzyl quinolone carboxylic acid (BQCA) designed to bind irreversibly to an allosteric site of the M ₁ muscarinic acetylcholine receptor.

期刊：Journal of medicinal chemistry发表年份：2014作者：Briana J Davie; Celine Valant; Jonathan M White; Patrick M Sexton; Ben Capuano; Arthur Christopoulos; Peter J Scammells
阅读更多 →

药效评价In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives.

期刊：British journal of pharmacology发表年份：2014作者：A Rizzi; D Malfacini; M C Cerlesi; C Ruzza; E Marzola; M F Bird; D J Rowbotham; S Salvadori; R Guerrini; D G Lambert; G Calo
阅读更多 →

药效评价Multifunctional D2/D3 agonist D-520 with high in vivo efficacy: modulator of toxicity of alpha-synuclein aggregates.

期刊：ACS chemical neuroscience发表年份：2014作者：Gyan Modi; Chandrashekhar Voshavar; Sanjib Gogoi; Mrudang Shah; Tamara Antonio; Maarten E A Reith; Aloke K Dutta
阅读更多 →

药效评价Identifying bias in CCR1 antagonists using radiolabelled binding, receptor internalization, β-arrestin translocation and chemotaxis assays.

期刊：British journal of pharmacology发表年份：2014作者：A Gilchrist; T D Gauntner; A Fazzini; K M Alley; D S Pyen; J Ahn; S J Ha; A Willett; S E Sansom; J L Yarfi; K A Bachovchin; M R Mazzoni; J R Merritt
阅读更多 →